<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26708" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Partial Epilepsy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Paula R.</given-names>
          </name>
          <aff>Wyckoff Heights Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>De Jesus</surname>
            <given-names>Orlando</given-names>
          </name>
          <aff>University of Puerto Rico, Medical Sciences Campus, Neurosurgery Section</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Paula Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Orlando De Jesus declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26708.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Partial seizures, also referred to as "focal seizures," affect a single brain area, with the temporal lobes being the most common occurrence site. They are associated with epilepsy. Despite the vast majority of partial seizures being harmless, sometimes the condition may be severe. To avoid complications, several antiepileptic medications are administered to patients with partial seizures after diagnosis. This activity reviews the evaluation and treatment of partial epilepsy and highlights the interprofessional team's role in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the pathophysiology of partial epilepsy.</p></list-item><list-item><p>Explain the clinical exam findings associated with partial epilepsy.</p></list-item><list-item><p>List the management options available for partial epilepsy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26708&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26708">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26708.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Seizure activity manifests when the brain's electrical impulses discharge abnormally, resulting in disrupting or dysregulation of normal neuronal communication. Seizures, whether isolated or recurrent, originate from the brain's cerebral cortex or hippocampus region.<xref ref-type="bibr" rid="article-26708.r1">[1]</xref>&#x000a0;The difference between a seizure and epilepsy depends on the number of episodes. A seizure is a single episode with a low risk of recurrence. In contrast, epilepsy is a disease in which two or more unprovoked&#x000a0;seizures occur more than 24 hours apart, or a single seizure episode with a probability of further seizures similar to the general recurrence risk after two unprovoked seizures occurring over the next ten years, specifically, 60% or higher.<xref ref-type="bibr" rid="article-26708.r2">[2]</xref>&#x000a0;The diagnosis of an epileptic syndrome includes seizures associated with&#x000a0;a common etiology, known prognosis, and accepted treatment. The predisposition of epileptic activity is determined by the underlying cause, whether known or unknown. An exception to this rule is fever in children. A child with a simple febrile seizure is typically not diagnosed with epilepsy because the seizure activity will subside when the fever resolves; however, complex febrile seizures are linked with epilepsy.</p>
        <p>The 2017 International League Against Epilepsy classification of seizures makes a point of the onset/origin of the seizure in the brain.<xref ref-type="bibr" rid="article-26708.r3">[3]</xref>&#x000a0;Seizures can be categorized as partial or generalized. Seizures&#x000a0;originating from&#x000a0;a single&#x000a0;location in the brain are considered to have a focal onset, known as a partial seizure. Seizure activity&#x000a0;originating simultaneously from bilateral hemispheres is considered to have a generalized onset. Partial seizures are further&#x000a0;divided into&#x000a0;simple and complex. Simple partial seizures&#x000a0;involve a small portion or a focal area of the brain. Complex partial seizures start in one area and travel to another. The main difference between a simple partial seizure and a complex partial seizure is&#x000a0;impaired&#x000a0;awareness and a post-ictal period in the latter, which also occurs in a generalized seizure. Thus complex partial seizures and generalized seizures may have similar presentations; however, they differ in that generalized seizures involve both hemispheres of the brain, whereas complex partial seizures travel from one focal area to another. Focal epilepsy&#x000a0;and&#x000a0;partial epilepsy are used interchangeably.</p>
        <p>The international classification also divides partial seizures into two categories based on their respective etiologies: idiopathic partial seizures in which the cause is suggested to have a genetic component, and cryptogenic/symptomatic partial seizures in which the cause is acquired.<xref ref-type="bibr" rid="article-26708.r4">[4]</xref><xref ref-type="bibr" rid="article-26708.r5">[5]</xref>&#x000a0;Partial seizures are further classified into simple partial seizures or seizures with auras. Aura's are sensations the patient experiences, in which the seizure activity manifests hallucinations involving visual, auditory, olfactory, tactile, or taste senses.<xref ref-type="bibr" rid="article-26708.r6">[6]</xref>&#x000a0;If a seizure does not follow the aura, it may be considered a focal aware&#x000a0;seizure&#x000a0;or simple partial.</p>
        <p>The diagnosis of epilepsy may negatively impact psychosocial behavior and cognitive function. Therefore, patients consequently develop comorbid conditions or manifest side effects of neuro-modulating medication. Thus, there is an increasingly evident demand for concurrent&#x000a0;interprofessional approaches to optimize the treatment of epilepsy in an effort to ensure a better quality of life.<xref ref-type="bibr" rid="article-26708.r7">[7]</xref></p>
      </sec>
      <sec id="article-26708.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of seizures varies widely across different age groups. Throughout the years, the influence of a genetic component in the development of partial seizures has become more prevalent.<xref ref-type="bibr" rid="article-26708.r4">[4]</xref>&#x000a0;Establishing the&#x000a0;exact cause or location of epileptogenesis can be&#x000a0;difficult,&#x000a0;at times, only through the process of elimination. The etiology of all epilepsies&#x000a0;is&#x000a0;classified under one of the following categories:&#x000a0;genetic, structural, metabolic, autoimmune, infectious, or unknown.&#x000a0;</p>
        <p>Mesial temporal lobe epilepsies (MTLE) are&#x000a0;identified as the most common form of partial epilepsy. The etiology of MTLE is linked to hippocampal sclerosis. Hippocampal sclerosis is caused by the disruption of normal mRNA transcription leading to various malfunctions of healthy cells and ultimately resulting in permanent sclerotic changes.<xref ref-type="bibr" rid="article-26708.r8">[8]</xref>&#x000a0;As the sclerotic tissue replaces healthy functioning tissue, the patient develops resistance to anti-epileptic medications&#x000a0;resulting in drug-resistant epilepsy.&#x000a0;</p>
        <p>&#x000a0;<bold>Genetic</bold></p>
        <list list-type="bullet">
          <list-item>
            <p>Idiopathic gene mutations with no family history of epilepsy</p>
          </list-item>
          <list-item>
            <p>Gene mutations with a family history of epilepsy</p>
          </list-item>
          <list-item>
            <p>Developmental disabilities</p>
            <list list-type="bullet">
              <list-item>
                <p>Autism spectrum disorder</p>
              </list-item>
            </list>
          </list-item>
        </list>
        <p>
<bold>Structural</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Blood vessel&#x000a0;pathology</p>
            <list list-type="bullet">
              <list-item>
                <p>Vascular lesions</p>
              </list-item>
              <list-item>
                <p>Stroke</p>
              </list-item>
              <list-item>
                <p>Abnormal blood vessels in the brain</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Developmental abnormalities</p>
            <list list-type="bullet">
              <list-item>
                <p>Arnold Chiari malformation</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Postsurgical changes</p>
          </list-item>
          <list-item>
            <p>Traumatic brain injuries</p>
          </list-item>
          <list-item>
            <p>Tumors&#x000a0;</p>
          </list-item>
        </list>
        <p>&#x000a0;<bold>Infectious</bold><xref ref-type="bibr" rid="article-26708.r9">[9]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Meningitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Focal encephalitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Human immunodeficiency virus</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cerebral malaria</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Subacute sclerosing panencephalitis&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Toxoplasmosis</p>
          </list-item>
          <list-item>
            <p>Neurocysticercosis&#x000a0;</p>
          </list-item>
        </list>
        <p><bold>Metabolic</bold>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Metabolic and electrolyte shifts</p>
          </list-item>
          <list-item>
            <p>Hypoxic insults</p>
          </list-item>
          <list-item>
            <p>Endocrine disorders</p>
          </list-item>
          <list-item>
            <p>Medications and toxins</p>
          </list-item>
          <list-item>
            <p>Alcohol</p>
            <list list-type="bullet">
              <list-item>
                <p>Alcohol intoxication</p>
              </list-item>
              <list-item>
                <p>Alcohol withdrawal</p>
              </list-item>
              <list-item>
                <p>Neonates with fetal alcohol syndrome<xref ref-type="bibr" rid="article-26708.r10">[10]</xref></p>
              </list-item>
            </list>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Drug abuse</p>
          </list-item>
          <list-item>
            <p>Complicated seizures with high fever</p>
          </list-item>
        </list>
        <p>
<bold>Autoimmune Disorders</bold>
<xref ref-type="bibr" rid="article-26708.r11">[11]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Systemic lupus erythematosus</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Sjogren syndrome</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Hashimoto encephalopathy&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Sjogren syndrome</p>
          </list-item>
          <list-item>
            <p>Chron disease</p>
          </list-item>
          <list-item>
            <p>Behcet disease</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26708.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Epilepsy affects over 68 million people globally, approximately 2.2 million people in the United States. With over 150,000 new cases diagnosed yearly, epilepsy has been established as one of the most common neuronal disorders.&#x000a0;By 20 years of age,&#x000a0;one out of every 100 people will develop epilepsy, whereas&#x000a0;three out of every 100 individuals will be diagnosed by age 80.</p>
        <p>Across North America, epilepsy is more common in racial and ethnic minorities and individuals from impoverished&#x000a0;backgrounds,&#x000a0;with&#x000a0;males affected at a slightly higher rate than females.<xref ref-type="bibr" rid="article-26708.r12">[12]</xref>&#x000a0;Partial&#x000a0;epilepsy exhibits a bi-modal distribution affecting the young and the elderly.<xref ref-type="bibr" rid="article-26708.r12">[12]</xref>&#x000a0;Simple partial&#x000a0;seizures occur in approximately&#x000a0;6&#x000a0;to 12% of patients with epilepsy.<xref ref-type="bibr" rid="article-26708.r13">[13]</xref>&#x000a0;Complex partial&#x000a0;seizures&#x000a0;occur in approximately 36% of patients with epilepsy.<xref ref-type="bibr" rid="article-26708.r14">[14]</xref></p>
        <p>In children, apart from febrile convulsions, the most prevalent form of partial&#x000a0;epilepsy is&#x000a0;benign partial epilepsy with centrotemporal spikes (benign rolandic epilepsy) occurring between the ages of 5 and 10.<xref ref-type="bibr" rid="article-26708.r4">[4]</xref> Glioneuronal&#x000a0;tumors typically arise from the temporal lobe presenting with focal epilepsy more commonly in children and adolescents.<xref ref-type="bibr" rid="article-26708.r15">[15]</xref></p>
      </sec>
      <sec id="article-26708.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The neuronal pathogenesis of epilepsy is not fully understood despite its high prevalence. Strong evidence suggests a genetic component affecting the transcription of specific principal neurons regulated by gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter. Subtypes of principal and GABAergic interneurons are the most likely candidates for contributing to seizure triggering and propagation.<xref ref-type="bibr" rid="article-26708.r1">[1]</xref>&#x000a0;</p>
        <p>Genetic predisposition to epilepsy has also been attributed to an upregulation&#x000a0;of the glutamate receptor genes, an excitatory neurotransmitter. As GABA becomes deregulated, the&#x000a0;glutamate receptor initiates an uninhibited, unsynchronized neuronal activity that generates a seizure activity. Structural lesions such as tumors, sclerotic tissue, or damaged tissue will serve as epileptogenic areas due to the disruption of normal electrical propagation.</p>
      </sec>
      <sec id="article-26708.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Tissue excised from the epileptogenic areas may show cortical dysplasia, cortical inflammation, neoplastic/dysplastic changes, or vascular malformations. For patients diagnosed with MTLE, a post mortem autopsy will&#x000a0;grossly show hippocampal sclerosis. On a cellular level, Hematoxylin and Eosin staining of cells excised from the&#x000a0;sclerotic tissue will&#x000a0;exhibit areas of dysplastic changes represented by small pink pools within the cytoplasm surrounding nucleolated nuclei.<xref ref-type="bibr" rid="article-26708.r16">[16]</xref>&#x000a0;</p>
        <p>For patients presenting with tumor-associated epilepsy, the histopathological characteristics will identify the type and classification&#x000a0;of the tumor, but these characteristics are not specific to partial epilepsy.<xref ref-type="bibr" rid="article-26708.r17">[17]</xref>&#x000a0;Similarly, seizures&#x000a0;attributed to&#x000a0;infectious and autoimmune diseases can be identified through histopathological analysis of cells acquired through tissue biopsy, a lumbar puncture, and cerebrospinal fluid analysis.</p>
      </sec>
      <sec id="article-26708.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A detailed history and physical are vital to accurately diagnose the type of seizure, find the probable cause, and determine recurrence risk. Patients may present with:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tingling</p>
          </list-item>
          <list-item>
            <p>Numbness</p>
          </list-item>
          <list-item>
            <p>Jerking movements</p>
          </list-item>
          <list-item>
            <p>Muscle tightening</p>
          </list-item>
          <list-item>
            <p>Staring into space</p>
          </list-item>
          <list-item>
            <p>Rapid eye movement</p>
          </list-item>
          <list-item>
            <p>Aura sensation or hallucinations
<list list-type="bullet"><list-item><p>Smells</p></list-item><list-item><p>Taste</p></list-item><list-item><p>Sight</p></list-item><list-item><p>Sounds or voices</p></list-item><list-item><p>Tactile sensation</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Clinical symptoms are determined&#x000a0;by the&#x000a0;anatomical areas affected, thus may facilitate the identification of the specific areas of epileptogenesis utilizing the topographical&#x000a0;representation of the cortical homunculus.<xref ref-type="bibr" rid="article-26708.r18">[18]</xref>&#x000a0;Partial epilepsies show common characteristics from the areas they arise from such areas.</p>
        <list list-type="bullet">
          <list-item>
            <p>Temporal - olfactory, psychomotor agitation, dysphagia&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Parietal - auditory</p>
          </list-item>
          <list-item>
            <p>Occipital - visual</p>
          </list-item>
          <list-item>
            <p>Frontal - loss of inhibition/cognition</p>
          </list-item>
          <list-item>
            <p>Postcentral gyrus - tingling, numbness</p>
          </list-item>
          <list-item>
            <p>Precentral gyrus - jerking movement, muscle tightening</p>
          </list-item>
        </list>
        <p>Complex partial seizures may present with an aura&#x000a0;sensation. When patients present with an aura type of partial seizures, they claim to see, taste, smell, hear, and feel a not-present sensation.&#x000a0;Complex partial epilepsy commonly arises from the temporal lobe causing cognitive and affective symptoms such as deja vu sensation or the ability to have psychic powers; some believe they are having conversations with God.<xref ref-type="bibr" rid="article-26708.r19">[19]</xref></p>
        <p>Patients can present autonomic dysfunction, motor, or sensory symptoms arising from the sensorimotor cortex in the temporal, parietal, or occipital lobes. The mouth, thumb, index finger, or great toe&#x000a0;are extremely sensitive to electrical discharges, and often the patient describes increased sensation in these areas&#x000a0;at the onset of seizure activity.</p>
      </sec>
      <sec id="article-26708.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Electroencephalogram (EEG)- an EEG is useful in detecting the origin of seizure&#x000a0;activity. In some cases, it may predict whether seizures will be controlled or uncontrolled. EEG may be normal once the seizure has been resolved.&#x000a0;EEG can be video recorded while the patients are exposed to stressors such as sleep deprivation, light stimulation, and hyperventilation to induce seizure activity in a controlled environment. Interictal spikes seen on the EEG at a focal site are suggestive of epilepsy. A drawback to scalp EEG is that if the seizure activity is generated from deeper areas within the brain, a more invasive procedure is required. A neurosurgical procedure is necessary to place intracranial electrodes in targeted areas.&#x000a0;</p>
        <p>Imaging studies to identify structural causes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Computed tomography scan of the head with and without contrast</p>
          </list-item>
          <list-item>
            <p>Magnetic resonance imaging of the brain with fluid-attenuated inversion recovery (FLAIR) sequence</p>
          </list-item>
          <list-item>
            <p>Interictal positron emission tomography&#x000a0;(PET)</p>
          </list-item>
          <list-item>
            <p>Ictal single-photon emission computerized tomography&#x000a0;(SPECT)</p>
          </list-item>
        </list>
        <p>Cardiac workup with an electrocardiogram (EKG) and Holter monitor.</p>
        <p>Laboratory analysis includes complete blood count, comprehensive metabolic panel, drug screen, blood alcohol level, toxin screen, and thyroid panel.&#x000a0;</p>
        <p>Consultations with neurologists, psychologists/psychiatrists, and social workers for an interdisciplinary team approach.</p>
      </sec>
      <sec id="article-26708.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>First and foremost, it is essential to identify, if possible, the cause and type of seizure. Benign focal epilepsy typically self-resolves and does not require further intervention. Simple partial epilepsy can be treated with an array of medications. There is no drug of choice, and the patient should be informed that a period of trial and error may ensue. Commonly used first-line&#x000a0;medications for partial epilepsy include carbamazepine and lamotrigine.&#x000a0;If seizures are not controlled, a second medication can be utilized including valproate, topiramate, oxcarbazepine, or gabapentin.</p>
        <p>Lamotrigine is the treatment of choice in the case of partial seizures associated with secondary generalization. Lamotrigine acts by blocking voltage-gated sodium channels. Lamotrigine is used in patients who do not tolerate, do not respond to, or have contraindications to valproate. Apart from partial seizures,&#x000a0;lamotrigine is also specifically used for Lennaux Gestaut syndrome. Lamotrigine is also used in treating bipolar disorder. A severe&#x000a0;adverse reaction associated with lamotrigine use is Stevens-Johnson syndrome, mainly when used with carbamazepine. Stevens-Johnson syndrome presents with a generalized rash, widespread bullae, and mucosal involvement. These bullae rapidly progress to denude the surface epithelium, potentially leading to severe dehydration and sepsis, among other complications. Treatment involves immediate cessation of the drug and supportive care. It can also cause toxic epidermal necrolysis.&#x000a0;</p>
        <p>Refractory (intractable) epilepsy has seizures that&#x000a0;cannot be controlled with two antiepileptic medications after titrating to the highest dose and attaining therapeutic levels in the blood. In patients&#x000a0;discontinuing medicines due to&#x000a0;side effects, the seizures are not considered refractory.<xref ref-type="bibr" rid="article-26708.r20">[20]</xref>&#x000a0;Alternative treatments are considered for these patients.</p>
        <list list-type="bullet">
          <list-item>
            <p>Neurostimulation treatments for intractable partial epilepsy are proven to reduce seizure activity. These treatments are well tolerated by patients and considered safe.<xref ref-type="bibr" rid="article-26708.r21">[21]</xref>&#x000a0; They are also beneficial for those discontinuing medication due to side effects as they reduced seizure activity.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Surgical intervention is reserved for&#x000a0;MTLE seizures secondary to sclerosis or seizures caused by structural lesions such as&#x000a0;surgically excisable tumors.&#x000a0;</p>
          </list-item>
        </list>
        <p>Adjunct therapy with diets high in protein, such as Atkins and ketogenic diets, has&#x000a0;reported benefits in patients experiencing refractory seizures.<xref ref-type="bibr" rid="article-26708.r22">[22]</xref><xref ref-type="bibr" rid="article-26708.r23">[23]</xref><xref ref-type="bibr" rid="article-26708.r24">[24]</xref><xref ref-type="bibr" rid="article-26708.r25">[25]</xref><xref ref-type="bibr" rid="article-26708.r26">[26]</xref><xref ref-type="bibr" rid="article-26708.r27">[27]</xref><xref ref-type="bibr" rid="article-26708.r28">[28]</xref>&#x000a0;However, close monitoring of&#x000a0;serum concentrations of antiepileptic drugs should be done as the diet may reduce serum concentrations and cause seizure aggravation.<xref ref-type="bibr" rid="article-26708.r29">[29]</xref></p>
        <p>Personalized, experimental treatment through reprogramming and reinsertion of patient-derived stem cells had shown promising results.<xref ref-type="bibr" rid="article-26708.r30">[30]</xref></p>
      </sec>
      <sec id="article-26708.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Partial epilepsy has a myriad of symptomatic presentations dependent on the focal area from where the seizure activity arises. Diagnostic considerations for new-onset seizure activity should include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Absence seizures</p>
          </list-item>
          <list-item>
            <p>Benign childhood epilepsy</p>
          </list-item>
          <list-item>
            <p>Complex partial seizures</p>
          </list-item>
          <list-item>
            <p>Transient ischemic attacks</p>
          </list-item>
          <list-item>
            <p>Atypical migraine</p>
          </list-item>
          <list-item>
            <p>Neuromuscular disorders</p>
          </list-item>
          <list-item>
            <p>Hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Alcohol withdrawal</p>
          </list-item>
          <list-item>
            <p>Drug intoxication</p>
          </list-item>
          <list-item>
            <p>Environmental toxins</p>
          </list-item>
          <list-item>
            <p>Panic attacks</p>
          </list-item>
          <list-item>
            <p>Thyroid diseases</p>
          </list-item>
          <list-item>
            <p>Malignancies
<list list-type="bullet"><list-item><p>Causing structural disruption within the brain</p></list-item><list-item><p>Causing metabolic disturbances
<list list-type="bullet"><list-item><p>Adrenal tumors</p></list-item><list-item><p>Renal tumors</p></list-item><list-item><p>Gastrointestinal tumors</p></list-item><list-item><p>Thyroid tumors</p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26708.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis&#x000a0;for partial epilepsy in children is favorable, with over 80% reduction in seizure activity over seven years.<xref ref-type="bibr" rid="article-26708.r31">[31]</xref>&#x000a0;Benign childhood seizures may not require further treatment in adulthood. Epilepsy was considered a diagnosis for life; however, the Task Force deems epilepsy as resolved in patients who are seizure-free&#x000a0;and medication-free for ten years. Terms such as "cured" and "remission" are not recommended as the risk of seizure activity does not fall to that of the general population.<xref ref-type="bibr" rid="article-26708.r2">[2]</xref></p>
      </sec>
      <sec id="article-26708.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Uncontrolled seizures can lead to cardiac arrhythmia and possibly death.</p>
        <p>Common side effects of medications include dizziness, nausea, vomiting, gingival hyperplasia, diarrhea. Serious and life-threatening side effects include QT prolongation on the EKG, agranulocytosis, depression, liver failure, hearing loss, pancreatitis.</p>
      </sec>
      <sec id="article-26708.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultation with a neurologist is the gold standard. If the underlying cause&#x000a0;is&#x000a0;difficult to ascertain, further consultations with cardiology, endocrine, and neurosurgery&#x000a0;may prove beneficial.</p>
        <p>Neuropsychiatric consultation can help diagnose the underlying cause; furthermore, this consultation serves a greater purpose as the prevalence of depression, or other concurrent psychiatric illnesses, is higher in patients suffering from chronic diseases like epilepsy.</p>
      </sec>
      <sec id="article-26708.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients must be educated on the triggers of their seizure activity, the side effects of medication, and the disease's prognosis. Parents/guardians of minors, along with the patient, should be educated. Adult patients deemed independent should be encouraged to include and educate spouses, significant others, family members, or trusted persons to ensure their safety.&#x000a0;</p>
        <p>Patients should be evaluated on an individual basis for safety and risk involved with driving, swimming, recreational sports, and hazardous work environments.&#x000a0;Uncontrolled seizures require extra safety precautions, including deterrence from driving, swimming, performing strenuous, or extreme sports activities.</p>
        <p>Patients with epilepsy require regular follow-ups appointments and long-term monitoring to observe medication efficacy, potential side effects, and the development of comorbid conditions.</p>
      </sec>
      <sec id="article-26708.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Partial epilepsy strongly affects a patient's lifestyle, secondary to the disruption of normal neurological processes. Patient-centered care requires an interdisciplinary, interprofessional team coordinating an evidence-based and holistic approach to optimizing patient outcomes and bettering their quality of life. The patient should have adequate follow-up care to assess for side effects of medication, medication adherence, clinical symptoms, accessibility to specialists, and comorbid conditions. Thus, an&#x000a0;interdisciplinary team to monitor and communicate between the&#x000a0;primary care physician, neurologist, psychiatrist, pharmacist, and social worker is mandatory.</p>
        <p>The Program to Encourage Active Rewarding Lives for Seniors&#x000a0;(PEARLS) enrolled older adults into a home-based program that integrated the patient with community outreach to detect and manage minor depression or dysthymia.<xref ref-type="bibr" rid="article-26708.r32">[32]</xref>&#x000a0;There is an increased risk of depression and suicide, regardless of age, linked to epileptic patients. In a randomized clinical trial that&#x000a0;enrolled adult epileptic participants using the PEARLS program,&#x000a0;a significant reduction in depression was obtained, with effects lasting more than one year after the end of the home visits.<xref ref-type="bibr" rid="article-26708.r33">[33]</xref><xref ref-type="bibr" rid="article-26708.r34">[34]</xref>&#x000a0;[Level&#x000a0;1] The PEARLS program had been utilized by the Epilepsy Foundation to decrease&#x000a0;depressive symptoms and improve the quality of life of adult patients with epilepsy using brief behavioral techniques during 6&#x000a0;to 8 home sessions.</p>
      </sec>
      <sec id="article-26708.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26708&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26708">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/partial-epilepsy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26708">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26708/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26708">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-26708.s17">
        <fig id="article-26708.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Normal EEG Contributed by Prabhu Emmady, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Normal__EEG" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-26708.s18">
        <fig id="article-26708.image.f2" position="float" orientation="portrait">
          <caption>
            <p>EEG with central temporal spikes Contributed by Arayamparambil Anilkumar, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="EEG_RL" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-26708.s19">
        <title>References</title>
        <ref id="article-26708.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pfisterer</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Petukhov</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Demharter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meichsner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Batiuk</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Asenjo-Martinez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vasistha</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Thakur</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mikkelsen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Adorjan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pinborg</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Pers</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>von Engelhardt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kharchenko</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Khodosevich</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis.</article-title>
            <source>Nat Commun</source>
            <year>2020</year>
            <month>Oct</month>
            <day>07</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>5038</fpage>
            <pub-id pub-id-type="pmid">33028830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Acevedo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arzimanoglou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bogacz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Elger</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Forsgren</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Glynn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hesdorffer</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Mathern</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Mosh&#x000e9;</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Perucca</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Scheffer</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Tomson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wiebe</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>ILAE official report: a practical clinical definition of epilepsy.</article-title>
            <source>Epilepsia</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>475</fpage>
            <page-range>475-82</page-range>
            <pub-id pub-id-type="pmid">24730690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mosh&#x000e9;</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>The evolution of the concepts of seizures and epilepsy: What's in a name?</article-title>
            <source>Epilepsia Open</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-35</page-range>
            <pub-id pub-id-type="pmid">32140641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berkovic</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Scheffer</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Genetics of human partial epilepsy.</article-title>
            <source>Curr Opin Neurol</source>
            <year>1997</year>
            <month>Apr</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>110</fpage>
            <page-range>110-4</page-range>
            <pub-id pub-id-type="pmid">9146992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <article-title>Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy.</article-title>
            <source>Epilepsia</source>
            <year>1989</year>
            <season>Jul-Aug</season>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>389</fpage>
            <page-range>389-99</page-range>
            <pub-id pub-id-type="pmid">2502382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Seizures and Epilepsy.</article-title>
            <source>Med Clin North Am</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>103</volume>
            <issue>2</issue>
            <fpage>309</fpage>
            <page-range>309-324</page-range>
            <pub-id pub-id-type="pmid">30704683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reger</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Hughes-Scalise</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Development of the transition-age program (TAP): Review of a pilot psychosocial multidisciplinary transition program in a Level 4 epilepsy center.</article-title>
            <source>Epilepsy Behav</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>89</volume>
            <fpage>153</fpage>
            <page-range>153-158</page-range>
            <pub-id pub-id-type="pmid">30415138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ozbas-Ger&#x000e7;eker</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Redeker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ozg&#x000fc;&#x000e7;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saygi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dalkara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Soylemezoglu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Akalan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Baayen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Gorter</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Aronica</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Serial analysis of gene expression in the hippocampus of patients with mesial temporal lobe epilepsy.</article-title>
            <source>Neuroscience</source>
            <year>2006</year>
            <volume>138</volume>
            <issue>2</issue>
            <fpage>457</fpage>
            <page-range>457-74</page-range>
            <pub-id pub-id-type="pmid">16413123</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singhi</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Infectious causes of seizures and epilepsy in the developing world.</article-title>
            <source>Dev Med Child Neurol</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>53</volume>
            <issue>7</issue>
            <fpage>600</fpage>
            <page-range>600-9</page-range>
            <pub-id pub-id-type="pmid">21518343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Newton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Khandai</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Luta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lovinger</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>N'Gouemo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Prenatal alcohol exposure in the second trimester-equivalent increases the seizure susceptibility in developing rats.</article-title>
            <source>Alcohol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>85</volume>
            <fpage>153</fpage>
            <page-range>153-164</page-range>
            <pub-id pub-id-type="pmid">32114257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devinsky</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Schein</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Najjar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Epilepsy associated with systemic autoimmune disorders.</article-title>
            <source>Epilepsy Curr</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>62</fpage>
            <page-range>62-8</page-range>
            <pub-id pub-id-type="pmid">23646005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>SPS</given-names>
              </name>
              <name>
                <surname>Pal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Adult onset seizures: Clinical, etiological, and radiological profile.</article-title>
            <source>J Family Med Prim Care</source>
            <year>2018</year>
            <season>Jan-Feb</season>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>191</fpage>
            <page-range>191-197</page-range>
            <pub-id pub-id-type="pmid">29915758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r13">
          <label>13</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ighodaro</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Maini</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Arya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Focal Onset Seizure</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>9</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">29763181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r14">
          <label>14</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ighodaro</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Focal Impaired Awareness Seizure</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>3</month>
            <day>19</day>
            <pub-id pub-id-type="pmid">30085572</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giulioni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rubboli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Marucci</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Martinoni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marliani</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Bartiromo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Calbucci</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Focal epilepsies associated with glioneuronal tumors: review article.</article-title>
            <source>Panminerva Med</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>225</fpage>
            <page-range>225-38</page-range>
            <pub-id pub-id-type="pmid">23676963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miyata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vinters</surname>
                <given-names>HV</given-names>
              </name>
            </person-group>
            <article-title>Surgical pathology of epilepsy-associated non-neoplastic cerebral lesions: a brief introduction with special reference to hippocampal sclerosis and focal cortical dysplasia.</article-title>
            <source>Neuropathology</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>442</fpage>
            <page-range>442-58</page-range>
            <pub-id pub-id-type="pmid">23530853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajneesh</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Binder</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Tumor-associated epilepsy.</article-title>
            <source>Neurosurg Focus</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>E4</fpage>
            <pub-id pub-id-type="pmid">19645560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feindel</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>The contributions of Wilder Penfield to the functional anatomy of the human brain.</article-title>
            <source>Hum Neurobiol</source>
            <year>1982</year>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>231</fpage>
            <page-range>231-4</page-range>
            <pub-id pub-id-type="pmid">6764468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benarroch</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>The central autonomic network: functional organization, dysfunction, and perspective.</article-title>
            <source>Mayo Clin Proc</source>
            <year>1993</year>
            <month>Oct</month>
            <volume>68</volume>
            <issue>10</issue>
            <fpage>988</fpage>
            <page-range>988-1001</page-range>
            <pub-id pub-id-type="pmid">8412366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jobst</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <article-title>Treatment algorithms in refractory partial epilepsy.</article-title>
            <source>Epilepsia</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>50 Suppl 8</volume>
            <fpage>51</fpage>
            <page-range>51-6</page-range>
            <pub-id pub-id-type="pmid">19702734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morrell</surname>
                <given-names>MJ</given-names>
              </name>
              <collab>RNS System in Epilepsy Study Group</collab>
            </person-group>
            <article-title>Responsive cortical stimulation for the treatment of medically intractable partial epilepsy.</article-title>
            <source>Neurology</source>
            <year>2011</year>
            <month>Sep</month>
            <day>27</day>
            <volume>77</volume>
            <issue>13</issue>
            <fpage>1295</fpage>
            <page-range>1295-304</page-range>
            <pub-id pub-id-type="pmid">21917777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sondhi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Agarwala</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Chakrabarty</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jauhari</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lodha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Toteja</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Kossoff</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gulati</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of Ketogenic Diet, Modified Atkins Diet, and Low Glycemic Index Therapy Diet Among Children With Drug-Resistant Epilepsy: A Randomized Clinical Trial.</article-title>
            <source>JAMA Pediatr</source>
            <year>2020</year>
            <month>Oct</month>
            <day>01</day>
            <volume>174</volume>
            <issue>10</issue>
            <fpage>944</fpage>
            <page-range>944-951</page-range>
            <pub-id pub-id-type="pmid">32761191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murugan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boison</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Ketogenic diet, neuroprotection, and antiepileptogenesis.</article-title>
            <source>Epilepsy Res</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>167</volume>
            <fpage>106444</fpage>
            <pub-id pub-id-type="pmid">32854046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tekin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Serdaro&#x0011f;lu</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>&#x0015e;ahin</surname>
                <given-names>&#x0015e;</given-names>
              </name>
              <name>
                <surname>Ta&#x0015f;demir</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Ketogenic diet experience at Ondokuz May&#x00131;s University.</article-title>
            <source>Neurol Sci</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>2481</fpage>
            <page-range>2481-2485</page-range>
            <pub-id pub-id-type="pmid">33104909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonald</surname>
                <given-names>TJW</given-names>
              </name>
              <name>
                <surname>Cervenka</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Ketogenic Diet Therapies for Seizures and Status Epilepticus.</article-title>
            <source>Semin Neurol</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>719</fpage>
            <page-range>719-729</page-range>
            <pub-id pub-id-type="pmid">33155184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poorshiri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Barzegar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tahmasebi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shiva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Raeisi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ebadi</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>The efficacy comparison of classic ketogenic diet and modified Atkins diet in children with refractory epilepsy: a clinical trial.</article-title>
            <source>Acta Neurol Belg</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>121</volume>
            <issue>2</issue>
            <fpage>483</fpage>
            <page-range>483-487</page-range>
            <pub-id pub-id-type="pmid">31677042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sourbron</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Klinkenberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van Kuijk</surname>
                <given-names>SMJ</given-names>
              </name>
              <name>
                <surname>Lagae</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lambrechts</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Braakman</surname>
                <given-names>HMH</given-names>
              </name>
              <name>
                <surname>Majoie</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Ketogenic diet for the treatment of pediatric epilepsy: review and meta-analysis.</article-title>
            <source>Childs Nerv Syst</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>1099</fpage>
            <page-range>1099-1109</page-range>
            <pub-id pub-id-type="pmid">32173786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wells</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Swaminathan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paseka</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hanson</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and Safety of a Ketogenic Diet in Children and Adolescents with Refractory Epilepsy-A Review.</article-title>
            <source>Nutrients</source>
            <year>2020</year>
            <month>Jun</month>
            <day>17</day>
            <volume>12</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">32560503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kverneland</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taub&#x000f8;ll</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Molteberg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Veier&#x000f8;d</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Selmer</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Nakken</surname>
                <given-names>KO</given-names>
              </name>
              <name>
                <surname>Iversen</surname>
                <given-names>PO</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetic interaction between modified Atkins diet and antiepileptic drugs in adults with drug-resistant epilepsy.</article-title>
            <source>Epilepsia</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>60</volume>
            <issue>11</issue>
            <fpage>2235</fpage>
            <page-range>2235-2244</page-range>
            <pub-id pub-id-type="pmid">31602644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lybrand</surname>
                <given-names>ZR</given-names>
              </name>
              <name>
                <surname>Goswami</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hsieh</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Stem cells: A path towards improved epilepsy therapies.</article-title>
            <source>Neuropharmacology</source>
            <year>2020</year>
            <month>May</month>
            <day>15</day>
            <volume>168</volume>
            <fpage>107781</fpage>
            <pub-id pub-id-type="pmid">31539537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Matricardi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guidetti</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Benedetti</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Prognosis of partial epilepsy.</article-title>
            <source>Arch Dis Child</source>
            <year>1988</year>
            <month>Oct</month>
            <volume>63</volume>
            <issue>10</issue>
            <fpage>1192</fpage>
            <page-range>1192-7</page-range>
            <pub-id pub-id-type="pmid">3143314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ciechanowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schmaling</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Diehr</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kulzer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Collier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>LoGerfo</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Community-integrated home-based depression treatment in older adults: a randomized controlled trial.</article-title>
            <source>JAMA</source>
            <year>2004</year>
            <month>Apr</month>
            <day>07</day>
            <volume>291</volume>
            <issue>13</issue>
            <fpage>1569</fpage>
            <page-range>1569-77</page-range>
            <pub-id pub-id-type="pmid">15069044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaytor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ciechanowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Unutzer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gilliam</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcomes from the PEARLS randomized trial for the treatment of depression in patients with epilepsy.</article-title>
            <source>Epilepsy Behav</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>545</fpage>
            <page-range>545-9</page-range>
            <pub-id pub-id-type="pmid">21333607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26708.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ciechanowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chaytor</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Unutzer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gilliam</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>PEARLS depression treatment for individuals with epilepsy: a randomized controlled trial.</article-title>
            <source>Epilepsy Behav</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>225</fpage>
            <page-range>225-31</page-range>
            <pub-id pub-id-type="pmid">20609631</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
